Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KardiganKARD -0.12%12 EV-to-OCF is -6.13 as of Sep. 20, 2026. GuruFocus rates KARD with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,406 Biotechnology companies, Kardigan ranks better than 68.42% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Kardigan's Enterprise Value is $981.01 Mil.
Kardigan's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-160.10 Mil. Therefore, Kardigan's EV-to-OCF for today is -6.13.
The historical rank and industry rank for Kardigan's EV-to-OCF or its related term are showing as below:
KARD'
s EV-to-OCF Range Over the Past 10 Years
Min: -11.41 Med: 0 Max: -8.84
Current: -9.14
During the past 2 years, the highest EV-to-OCF of Kardigan was -8.84. The lowest was -11.41. And the median was .
KARD's EV-to-OCF is ranked better than 68.42% of 1406
companies
in the Biotechnology industry
Industry Median: -3.37
vs KARD: -9.14
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kardigan's share price for today is $16.64.
Kardigan's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.871.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Kardigan EV-to-OCF Related Terms
Kardigan EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Kardigan's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kardigan EV-to-OCF Chart
Kardigan Annual Data
Trend
Dec24
Dec25
EV-to-OCF
-
-
Kardigan Quarterly Data
Mar25
Jun25
Mar26
Jun26
EV-to-OCF
-
-
-
-32.54
KARD vs TSHA, VIR, GHRS: EV-to-OCF Comparison
For the Biotechnology subindustry, Kardigan's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kardigan EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kardigan's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Kardigan's EV-to-OCF falls into.
Kardigan's current Enterprise Value is $981.01 Mil.
Kardigan's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-160.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kardigan (KARD) has a EV-to-OCF of -6.13 as of Sep. 20, 2026. According to the industry distribution chart, Kardigan ranks #444 out of 1406 companies in the Biotechnology industry, placing it in the top 31.6%.
Is Kardigan's EV-to-OCF too high?
Kardigan's current EV-to-OCF is -6.13. Based on the distribution chart, Kardigan ranks #444 out of 1406 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Kardigan has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kardigan's EV-to-OCF compare to TSHA and VIR?
According to the Biotechnology industry distribution chart, Kardigan ranks #444 out of 1406 companies for EV-to-OCF. This puts Kardigan in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Kardigan's current EV-to-OCF is -6.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kardigan stock overvalued right now?
Kardigan (KARD) has a current EV-to-OCF of -6.13. The current EV-to-OCF is -6.13. Kardigan's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Kardigan (KARD), the current EV-to-OCF is -6.13 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
12GF Score
Get the complete analysis for KARD
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KARD has been successfully added to your 
